Eli Lilly's Fiscal 2016 Earnings: Analyzing The Surprising Results

Eli Lilly's Fiscal 2016 Earnings: Analyzing The Surprising Results


Shares of pharmaceutical giant Eli Lilly rose 3% on Jan. 31, after the company reported better-than-expected financial results for the fourth quarter. Eli Lilly has had a difficult time over past few years.



from Biotech News